# Study to Compare the Effects of Two Dosages of Tolvaptan in Congestive Heart Failure Patients

> **NCT00043771** · PHASE2 · COMPLETED · sponsor: **Otsuka Pharmaceutical Development & Commercialization, Inc.** · enrollment: 40 (—)

## Conditions studied

- Congestive Heart Failure

## Interventions

- **DRUG:** Tolvaptan

## Key facts

- **NCT ID:** NCT00043771
- **Lead sponsor:** Otsuka Pharmaceutical Development & Commercialization, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2002-05
- **Primary completion:** —
- **Final completion:** 2002-09
- **Target enrollment:** 40 (—)
- **Last updated:** 2005-06-24


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00043771

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00043771, "Study to Compare the Effects of Two Dosages of Tolvaptan in Congestive Heart Failure Patients". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT00043771. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*